6-Bromohexanoic acid - CAS 4224-70-8
Catalog: |
BB025087 |
Product Name: |
6-Bromohexanoic acid |
CAS: |
4224-70-8 |
Synonyms: |
6-bromohexanoic acid |
IUPAC Name: | 6-bromohexanoic acid |
Description: | 6-Bromohexanoic acid (CAS# 4224-70-8) is useful for the preparation of anti-CTLA4 compounds as antitumor agents. |
Molecular Weight: | 195.05 |
Molecular Formula: | C6H11BrO2 |
Canonical SMILES: | C(CCC(=O)O)CCBr |
InChI: | InChI=1S/C6H11BrO2/c7-5-3-1-2-4-6(8)9/h1-5H2,(H,8,9) |
InChI Key: | NVRVNSHHLPQGCU-UHFFFAOYSA-N |
Boiling Point: | 165-170 °C (20 mmHg) |
Melting Point: | 32-35 °C |
Purity: | > 96.0 % (GC) (T) |
Density: | 1.44 g/cm3 |
Appearance: | White to light orange low melting crystals |
Storage: | 2-8 °C |
MDL: | MFCD00004422 |
LogP: | 2.02630 |
GHS Hazard Statement: | H314 (100%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation] |
Precautionary Statement: | P260, P264, P280, P301+P330+P331, P303+P361+P353, P304+P340, P305+P351+P338, P310, P321, P363, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CN-113462186-A | sulfo-Cy 3 carboxylic acid fluorescent dye and preparation process thereof | 20210823 |
CN-113264842-A | Lipid compound, lipid carrier containing same, nucleic acid lipid nanoparticle composition and pharmaceutical preparation | 20210721 |
CN-113480418-A | New compound and application thereof in preparing medicine for treating cancer | 20210713 |
CN-113350336-A | Application of heptamethine indocyanine or derivative thereof | 20210701 |
CN-113308131-A | Carboxyl modified near-infrared squaric acid dye and preparation method and application thereof | 20210526 |
PMID | Publication Date | Title | Journal |
21994883 | 20120101 | Pathological features of new animal models for primary biliary cirrhosis | International journal of hepatology |
22007316 | 20120101 | PBC: Animal Models of Cholangiopathies and Possible Endogenous Viral Infections | International journal of hepatology |
21727893 | 20110704 | Synthesis and anticancer activity of some new s-glycosyl and s-alkyl 1,2,4-triazinone derivatives | Molecules (Basel, Switzerland) |
22295019 | 20110601 | Environmental pathways to autoimmune diseases: the cases of primary biliary cirrhosis and multiple sclerosis | Archives of medical science : AMS |
20930861 | 20110101 | Modified polyethyleneimine with histidine-lysine short peptides as gene carrier | Cancer gene therapy |
Complexity: | 83.1 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 193.99424 |
Formal Charge: | 0 |
Heavy Atom Count: | 9 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 193.99424 |
Rotatable Bond Count: | 5 |
Topological Polar Surface Area: | 37.3 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS